Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062822-26-000029
Filing Date
2026-02-18
Accepted
2026-02-18 16:30:52
Documents
1
Period of Report
2026-02-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 9999
  Complete submission text file 0001062822-26-000029.txt   11702
Mailing Address C/O THE INVUS GROUP, LLC 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address
DEBBANE RAYMOND (Reporting) CIK: 0001053890 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30111 | Film No.: 26648937

Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Issuer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)